Adicet Bio Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Adicet Bio, Inc. (ACET) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-117.12-142.66-69.79-62.00-36.68
Depreciation & Amortization6.476.102.671.721.23
Deferred Income Tax0.000.000.000.00-0.24
Stock Based Compensation22.2320.2617.1312.515.26
Change in Working Capital-5.530.255.01-5.55-13.52
Change in Accounts Receivable0.000.000.00-0.030.00
Change in Accounts Payable1.11-1.681.711.14-0.81
Change in Other Working Capital-6.632.875.841.72-4.81
Other Operating Activities1.572.8717.3015.75-0.28
Net Cash from Operating Activities-92.38-93.72-44.77-51.05-41.55
Investing Activities
Capital Expenditures-1.12-4.4616.7813.05-0.99
Acquisitions0.000.000.00-0.9864.11
Purchases of Investments-129.120.000.0010.2552.09
Sales/Maturities of Investments11.000.000.0010.2552.09
Other Investing Activities0.000.000.007.500.00
Net Cash from Investing Activities-119.24-4.46-16.78-2.80115.22
Financing Activities
Debt Repayment0.000.00-0.36-0.26-0.16
Common Stock Issued110.920.3943.79238.260.46
Common Stock Repurchased0.00-0.15-3.230.000.00
Other Financing Activities0.39-0.15-3.23-0.26-0.16
Net Cash from Financing Activities111.310.2441.51242.690.30
Summary
Net Change in Cash-100.31-97.95-20.04188.8473.97
Cash at Beginning of Period159.71257.66277.6988.8614.89
Cash at End of Period59.40159.71257.66277.6988.86
Free Cash Flow-93.50-98.18-61.55-64.10-42.54
Supplemental Disclosures
Income Taxes Paid0.000.000.000.04-0.66